Table 3 Final Cox proportional odds regression model
Variable | B | SE | Wald | p | Hazard ratio | 95,0% CI for Exp(B) | |
|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Â | Â | Lower | Upper |
PS(60 vs ≤ 50) | ,376 | ,268 | 1,966 | ,161 | 1,456 | ,861 | 2,461 |
PS(70 vs ≤ 50) | -,501 | ,319 | 2,467 | ,116 | ,606 | ,324 | 1,132 |
PS(80 vs ≤ 50) | -1,180 | ,345 | 11,676 | ,001 | ,307 | ,156 | ,605 |
PS(90 vs ≤ 50) | -1,357 | ,420 | 10,437 | ,001 | ,257 | ,113 | ,586 |
PRIMARY EXTENT(4 vs 1) | ,085 | ,489 | ,030 | ,862 | 1,088 | ,418 | 2,836 |
PRIMARY EXTENT (3 vs 1) | ,399 | ,495 | ,649 | ,420 | 1,491 | ,564 | 3,936 |
PRIMARY EXTENT (2 vs 1) | 1,015 | ,518 | 3,838 | ,050 | 2,758 | 1,000 | 7,610 |
DISTANT METASTASES (yes vs no) | ,949 | ,247 | 14,730 | ,000 | 2,583 | 1,591 | 4,194 |
PLOIDY (3.6+ vs <2.2) | 1,605 | ,341 | 22,093 | ,000 | 4,975 | 2,548 | 9,714 |
PLOIDY (2.2–3.6 vs <2.2) | 1,846 | ,375 | 24,251 | ,000 | 6,333 | 3,038 | 13,201 |
EPOETIN – ANEMIA (yes vs no) | -,441 | ,184 | 5,779 | ,016 | ,643 | ,449 | ,922 |
WEIGHT LOSS (none vs 10+) | -,536 | ,379 | 1,997 | ,158 | ,585 | ,278 | 1,230 |
WEIGHT LOSS (1–5% vs 10+) | -1,081 | ,330 | 10,719 | ,001 | ,339 | ,178 | ,648 |
WEIGHT LOSS (5–10% vs10+) | -1,097 | ,268 | 16,756 | ,000 | ,334 | ,197 | ,565 |
PAIN (none vs severe) | -,360 | ,355 | 1,028 | ,311 | ,698 | ,348 | 1,399 |
PAIN (light vs severe) | -,224 | ,286 | ,613 | ,434 | ,799 | ,456 | 1,400 |
PAIN (moderate vs severe) | -,769 | ,281 | 7,486 | ,006 | ,463 | ,267 | ,804 |
STEATORIA (yes vs no) | ,585 | ,183 | 10,185 | ,001 | 1,795 | 1,253 | 2,572 |
CEA (>5 vs <= 5) | ,345 | ,161 | 4,586 | ,032 | 1,413 | 1,030 | 1,938 |
THERAPY (CT vs none) | -1,449 | ,272 | 28,445 | ,000 | ,235 | ,138 | ,400 |
THERAPY (Surgery vs none) | -,416 | ,254 | 2,669 | ,102 | ,660 | ,401 | 1,087 |
THERAPY(both vs none) | -1,903 | ,270 | 49,641 | ,000 | ,149 | ,088 | ,253 |